CollPlant Biotechnologies (CLGN) Receivables - Other (2017 - 2025)
CollPlant Biotechnologies (CLGN) posted Receivables - Other of $210000.0 for Q4 2025, up 625.0% on a QoQ basis from -$40000.0 in Q4 2024, and up 625.0% year-over-year from $28965.5 in Q4 2024.
CollPlant Biotechnologies (CLGN) Receivables - Other (2017 - 2025) Analysis & Trends
CollPlant Biotechnologies' Receivables - Other history runs 9 years deep, the most recent figure standing at $210000.0 for Q4 2025.
- Quarterly Receivables - Other rose 625.0% year-over-year to $210000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $210000.0 (up 625.0% YoY) and the FY2025 annual result came in at $210000.0, up 625.0% from the prior year.
- Receivables - Other was $210000.0 for Q4 2025 at CollPlant Biotechnologies, up from -$40000.0 in the prior quarter.
- Across five years, Receivables - Other topped out at $210000.0 in Q4 2025 and bottomed at -$740000.0 in Q2 2021.
- A 5-year average of -$88076.9 and a median of -$40000.0 in 2024 frame the typical range for Receivables - Other.
- Annual changes were most pronounced in 2021 — Receivables - Other sank 696.77% — and 2022, when it surged 675.0%.
- CollPlant Biotechnologies' Receivables - Other stood at -$185000.0 in 2021, then surged by 35.68% to -$119000.0 in 2022, then surged by 226.05% to $150000.0 in 2023, then tumbled by 126.67% to -$40000.0 in 2024, then surged by 625.0% to $210000.0 in 2025.
- Business Quant data shows CLGN's Receivables - Other at $210000.0 in Q4 2025, -$40000.0 in Q4 2024, and $150000.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | CollPlant Biotechnologies | 4.63 Mn | 4.63 Mn | -243,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 210,000.00 |
| Dec 31, 2025 | 210,000.00 |
| Dec 31, 2024 | -40,000.00 |
| Dec 31, 2024 | -40,000.00 |
| Dec 31, 2023 | 150,000.00 |
| Dec 31, 2023 | 150,000.00 |
| Sep 30, 2023 | 50,000.00 |
| Sep 30, 2023 | 50,000.00 |
| Mar 31, 2023 | 135,000.00 |
| Mar 31, 2023 | 135,000.00 |
| Dec 31, 2022 | -119,000.00 |
| Dec 31, 2022 | -119,000.00 |
| Sep 30, 2022 | -65,000.00 |
| Sep 30, 2022 | -65,000.00 |
| Jun 30, 2022 | -170,000.00 |
| Jun 30, 2022 | -170,000.00 |
| Mar 31, 2022 | 161,000.00 |
| Mar 31, 2022 | 161,000.00 |
| Dec 31, 2021 | -185,000.00 |
| Dec 31, 2021 | -185,000.00 |